<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37242804</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1999-4923</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Pharmaceutics</Title><ISOAbbreviation>Pharmaceutics</ISOAbbreviation></Journal><ArticleTitle>Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1562</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pharmaceutics15051562</ELocationID><Abstract><AbstractText>Coronavirus infections are neuroinvasive and can provoke injury to the central nervous system (CNS) and long-term illness consequences. They may be associated with inflammatory processes due to cellular oxidative stress and an imbalanced antioxidant system. The ability of phytochemicals with antioxidant and anti-inflammatory activities, such as Ginkgo biloba, to alleviate neurological complications and brain tissue damage has attracted strong ongoing interest in the neurotherapeutic management of long COVID. Ginkgo biloba leaf extract (EGb) contains several bioactive ingredients, e.g., bilobalide, quercetin, ginkgolides A-C, kaempferol, isorhamnetin, and luteolin. They have various pharmacological and medicinal effects, including memory and cognitive improvement. Ginkgo biloba, through its anti-apoptotic, antioxidant, and anti-inflammatory activities, impacts cognitive function and other illness conditions like those in long COVID. While preclinical research on the antioxidant therapies for neuroprotection has shown promising results, clinical translation remains slow due to several challenges (e.g., low drug bioavailability, limited half-life, instability, restricted delivery to target tissues, and poor antioxidant capacity). This review emphasizes the advantages of nanotherapies using nanoparticle drug delivery approaches to overcome these challenges. Various experimental techniques shed light on the molecular mechanisms underlying the oxidative stress response in the nervous system and help comprehend the pathophysiology of the neurological sequelae of SARS-CoV-2 infection. To develop novel therapeutic agents and drug delivery systems, several methods for mimicking oxidative stress conditions have been used (e.g., lipid peroxidation products, mitochondrial respiratory chain inhibitors, and models of ischemic brain damage). We hypothesize the beneficial effects of EGb in the neurotherapeutic management of long-term COVID-19 symptoms, evaluated using either in vitro cellular or in vivo animal models of oxidative stress.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akanchise</LastName><ForeName>Thelma</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0550-1317</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelova</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0285-0637</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceutics</MedlineTA><NlmUniqueID>101534003</NlmUniqueID><ISSNLinking>1999-4923</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ginkgo biloba bioactive compounds</Keyword><Keyword MajorTopicYN="N">anti-inflammatory and anti-apoptotic agents</Keyword><Keyword MajorTopicYN="N">in vivo and in vitro models</Keyword><Keyword MajorTopicYN="N">nanoparticle therapeutic efficacy</Keyword><Keyword MajorTopicYN="N">nanotherapy</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuroinvasive coronavirus infection</Keyword><Keyword MajorTopicYN="N">neurological long COVID</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37242804</ArticleId><ArticleId IdType="pmc">PMC10224264</ArticleId><ArticleId IdType="doi">10.3390/pharmaceutics15051562</ArticleId><ArticleId IdType="pii">pharmaceutics15051562</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An Overview. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieczfinska J., Kleniewska P., Pawliczak R. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections. Oxidative Med. Cell. Longev. 2022;2022:5589089. doi: 10.1155/2022/5589089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5589089</ArticleId><ArticleId IdType="pmc">PMC8906126</ArticleId><ArticleId IdType="pubmed">35281470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kase Y., Okano H. Neurological Pathogenesis of SARS-CoV-2 (COVID-19): From Virological Features to Clinical Symptoms. Inflamm. Regen. 2021;41:15. doi: 10.1186/s41232-021-00165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-021-00165-8</ArticleId><ArticleId IdType="pmc">PMC8103065</ArticleId><ArticleId IdType="pubmed">33962695</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D., Picone P. Potential Neurological Effects of Severe COVID-19 Infection. Neurosci. Res. 2020;158:1&#x2013;5. doi: 10.1016/j.neures.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7333632</ArticleId><ArticleId IdType="pubmed">32628969</ArticleId></ArticleIdList></Reference><Reference><Citation>Edinoff A.N., Chappidi M., Alpaugh E.S., Turbeville B.C., Falgoust E.P., Cornett E.M., Murnane K.S., Kaye A.M., Kaye A.D. Neurological and Psychiatric Symptoms of COVID-19: A Narrative Review. Psychiatry Int. 2022;3:158&#x2013;168. doi: 10.3390/psychiatryint3020013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/psychiatryint3020013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 Symptom Burden: What Is Long-COVID and How Should We Manage It? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID Endotheliopathy: Hypothesized Mechanisms and Potential Therapeutic Approaches. J. Clin. Investig. 2022;132:e161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Cristillo V., Cotti Piccinelli S., Zoppi N., Bonzi G., Sattin D., Schiavolin S., Raggi A., Canale A., Gipponi S., et al. Long-Term Neurological Manifestations of COVID-19: Prevalence and Predictive Factors. Neurol. Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. Lancet Respir. Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., et al. Neurological Outcomes 1 Year after COVID-19 Diagnosis: A Prospective Longitudinal Cohort Study. Euro. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.-C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa C., Rivellini E., Lavitrano M., Combi R. Can SARS-CoV-2 Infection Exacerbate Alzheimer&#x2019;s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms. JPM. 2022;12:29. doi: 10.3390/jpm12010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12010029</ArticleId><ArticleId IdType="pmc">PMC8780286</ArticleId><ArticleId IdType="pubmed">35055344</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues R.B., Mendes-Correa M.C., de Moura Leite F.B.V., Sabino E.C., Salarini D.Z., Claro I., Santos D.W., de Jesus J.G., Ferreira N.E., Romano C.M., et al. First Case of SARS-COV-2 Sequencing in Cerebrospinal Fluid of a Patient with Suspected Demyelinating Disease. J. Neurol. 2020;267:3154&#x2013;3156. doi: 10.1007/s00415-020-09996-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09996-w</ArticleId><ArticleId IdType="pmc">PMC7305694</ArticleId><ArticleId IdType="pubmed">32564153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchi&#xe9; A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., et al. Endothelial Dysfunction and Immunothrombosis as Key Pathogenic Mechanisms in COVID-19. Nat. Rev. Immunol. 2021;21:319&#x2013;329. doi: 10.1038/s41577-021-00536-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage S.L., Amaral E.P., Hilligan K.L., Laidlaw E., Rupert A., Namasivayan S., Rocco J., Galindo F., Kellogg A., Kumar P., et al. Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16&#x2212; Monocytes From COVID-19 Patients. Front. Immunol. 2022;12:799558. doi: 10.3389/fimmu.2021.799558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.799558</ArticleId><ArticleId IdType="pmc">PMC8795739</ArticleId><ArticleId IdType="pubmed">35095880</ArticleId></ArticleIdList></Reference><Reference><Citation>Blesa J., Trigo-Damas I., Quiroga-Varela A., Jackson-Lewis V.R. Oxidative Stress and Parkinson&#x2019;s Disease. Front. Neuroanat. 2015;9:91. doi: 10.3389/fnana.2015.00091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2015.00091</ArticleId><ArticleId IdType="pmc">PMC4495335</ArticleId><ArticleId IdType="pubmed">26217195</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y., Zhu G.-H., Wang H.-N., Hu Q., Chen L.-L., Guan X.-Q., Li H.-L., Chen H.-Z., Tang H., Ge G.-B. Discovery of Naturally Occurring Inhibitors against SARS-CoV-2 3CLpro from Ginkgo Biloba Leaves via Large-Scale Screening. Fitoterapia. 2021;152:104909. doi: 10.1016/j.fitote.2021.104909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2021.104909</ArticleId><ArticleId IdType="pmc">PMC8061081</ArticleId><ArticleId IdType="pubmed">33894315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Cui Q., Cooper L., Zhang P., Lee H., Chen Z., Wang Y., Liu X., Rong L., Du R. Ginkgolic Acid and Anacardic Acid Are Specific Covalent Inhibitors of SARS-CoV-2 Cysteine Proteases. Cell Biosci. 2021;11:45. doi: 10.1186/s13578-021-00564-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00564-x</ArticleId><ArticleId IdType="pmc">PMC7914117</ArticleId><ArticleId IdType="pubmed">33640032</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor-E-Tabassum, Das R., Lami M.S., Chakraborty A.J., Mitra S., Tallei T.E., Idroes R., Mohamed A.A.-R., Hossain M.J., Dhama K., et al. Ginkgo Biloba: A Treasure of Functional Phytochemicals with Multimedicinal Applications. Evid. Based Complement. Altern. Med. 2022;2022:8288818. doi: 10.1155/2022/8288818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/8288818</ArticleId><ArticleId IdType="pmc">PMC8901348</ArticleId><ArticleId IdType="pubmed">35265150</ArticleId></ArticleIdList></Reference><Reference><Citation>Sochocka M., Ochnik M., Sobczy&#x144;ski M., G&#x119;bura K., Zambrowicz A., Naporowski P., Leszek J. Ginkgo Biloba Leaf Extract Improves an Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer&#x2019;s Disease Patients. Nutrients. 2022;14:2022. doi: 10.3390/nu14102022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102022</ArticleId><ArticleId IdType="pmc">PMC9147830</ArticleId><ArticleId IdType="pubmed">35631163</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbalho S.M., Direito R., Laurindo L.F., Marton L.T., Guiguer E.L., Goulart R.D.A., Tofano R.J., Carvalho A.C.A., Flato U.A.P., Capelluppi Tofano V.A., et al. Ginkgo Biloba in the Aging Process: A Narrative Review. Antioxidants. 2022;11:525. doi: 10.3390/antiox11030525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11030525</ArticleId><ArticleId IdType="pmc">PMC8944638</ArticleId><ArticleId IdType="pubmed">35326176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomino C., Ilari S., Solfrizzi V., Malafoglia V., Zilio G., Russo P., Proietti S., Marcolongo F., Scapagnini G., Muscoli C., et al. Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo Biloba (EGb 761&#xae;) Pharmaceuticals. 2021;14:305. doi: 10.3390/ph14040305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14040305</ArticleId><ArticleId IdType="pmc">PMC8065464</ArticleId><ArticleId IdType="pubmed">33915701</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S.K., Srivastav S., Castellani R.J., Plascencia-Villa G., Perry G. Neuroprotective and Antioxidant Effect of Ginkgo Biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019;16:666&#x2013;674. doi: 10.1007/s13311-019-00767-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00767-8</ArticleId><ArticleId IdType="pmc">PMC6694352</ArticleId><ArticleId IdType="pubmed">31376068</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-kuraishy H.M., Al-Gareeb A.I., Kaushik A., Kujawska M., Batiha G.E. Ginkgo Biloba in the Management of the COVID-19 Severity. Arch. Pharm. 2022;355:2200188. doi: 10.1002/ardp.202200188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ardp.202200188</ArticleId><ArticleId IdType="pmc">PMC9348126</ArticleId><ArticleId IdType="pubmed">35672257</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome. ACS Chem. Neurosci. 2020;11:4017&#x2013;4020. doi: 10.1021/acschemneuro.0c00725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00725</ArticleId><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Zhang M., Wang J., Gao J. Sars-Cov-2: Underestimated Damage to Nervous System. Travel Med. Infect. Dis. 2020;36:101642. doi: 10.1016/j.tmaid.2020.101642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101642</ArticleId><ArticleId IdType="pmc">PMC7269702</ArticleId><ArticleId IdType="pubmed">32220634</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Sidney J., Zhang Y., Scheuermann R.H., Peters B., Sette A. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe. 2020;27:671&#x2013;680.e2. doi: 10.1016/j.chom.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.03.002</ArticleId><ArticleId IdType="pmc">PMC7142693</ArticleId><ArticleId IdType="pubmed">32183941</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N., C&#xf4;t&#xe9; G., Lachance C., Tardieu M., Cashman N.R., Talbot P.J. Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43. J. Virol. 1999;73:3338&#x2013;3350. doi: 10.1128/JVI.73.4.3338-3350.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.4.3338-3350.1999</ArticleId><ArticleId IdType="pmc">PMC104098</ArticleId><ArticleId IdType="pubmed">10074188</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins A.R., Sorensen O. Regulation of Viral Persistence in Human Glioblastoma and Rhabdomyosarcoma Cells Infected with Coronavirus OC43. Microb. Pathog. 1986;1:573&#x2013;582. doi: 10.1016/0882-4010(86)90042-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0882-4010(86)90042-2</ArticleId><ArticleId IdType="pmc">PMC7135842</ArticleId><ArticleId IdType="pubmed">2854604</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan&#xe1;-Cuevas P., Salles-G&#xe1;ndara P., Rojas-Fernandez A., Salinas-Rebolledo C., Mil&#xe1;n-Sol&#xe9; A. The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson&#x2019;s Disease. Front. Neurol. 2020;11:1044. doi: 10.3389/fneur.2020.01044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01044</ArticleId><ArticleId IdType="pmc">PMC7527541</ArticleId><ArticleId IdType="pubmed">33041985</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroujeni M.E., Simani L., Bluyssen H.A.R., Samadikhah H.R., Zamanlui Benisi S., Hassani S., Akbari Dilmaghani N., Fathi M., Vakili K., Mahmoudiasl G.-R., et al. Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19. ACS Chem. Neurosci. 2021;12:2143&#x2013;2150. doi: 10.1021/acschemneuro.1c00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00111</ArticleId><ArticleId IdType="pubmed">34100287</ArticleId></ArticleIdList></Reference><Reference><Citation>Palpagama T.H., Waldvogel H.J., Faull R.L.M., Kwakowsky A. The Role of Microglia and Astrocytes in Huntington&#x2019;s Disease. Front. Mol. Neurosci. 2019;12:258. doi: 10.3389/fnmol.2019.00258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00258</ArticleId><ArticleId IdType="pmc">PMC6824292</ArticleId><ArticleId IdType="pubmed">31708741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous System Involvement after Infection with COVID-19 and Other Coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Bai W., Hashikawa T. Response to Commentary on &#x201c;The Neuroinvasive Potential of SARS-CoV-2 May Play a Role in the Respiratory Failure of COVID-19 Patients&#x201d;. J. Med. Virol. 2020;92:707&#x2013;709. doi: 10.1002/jmv.25824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25824</ArticleId><ArticleId IdType="pmc">PMC7228344</ArticleId><ArticleId IdType="pubmed">32246783</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C.A., Lagier J.-C., Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front. Med. 2021;8:640073. doi: 10.3389/fmed.2021.640073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.640073</ArticleId><ArticleId IdType="pmc">PMC7930624</ArticleId><ArticleId IdType="pubmed">33681266</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Q., Fan L., Liu W., Li J., Yue J., Wang M., Ke X., Yin Y., Chen Q., Jiang C. Direct Evidence of Active SARS-CoV-2 Replication in the Intestine. Clin. Infect. Dis. 2021;73:361&#x2013;366. doi: 10.1093/cid/ciaa925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa925</ArticleId><ArticleId IdType="pmc">PMC7454471</ArticleId><ArticleId IdType="pubmed">32638022</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann M., Allers K., Heldt C., Meinhardt J., Schmidt F., Rodriguez-Sillke Y., Kunkel D., Schumann M., B&#xf6;ttcher C., Stahl-Hennig C., et al. Human Small Intestinal Infection by SARS-CoV-2 Is Characterized by a Mucosal Infiltration with Activated CD8+ T Cells. Mucosal Immunol. 2021;14:1381&#x2013;1392. doi: 10.1038/s41385-021-00437-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00437-z</ArticleId><ArticleId IdType="pmc">PMC8379580</ArticleId><ArticleId IdType="pubmed">34420043</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser M.C., Tansey M.G. The Gut-Brain Axis: Is Intestinal Inflammation a Silent Driver of Parkinson&#x2019;s Disease Pathogenesis? NPJ Park. Dis. 2017;3:3. doi: 10.1038/s41531-016-0002-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-016-0002-0</ArticleId><ArticleId IdType="pmc">PMC5445611</ArticleId><ArticleId IdType="pubmed">28649603</ArticleId></ArticleIdList></Reference><Reference><Citation>Politi L.S., Salsano E., Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020;77:1028. doi: 10.1001/jamaneurol.2020.2125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2125</ArticleId><ArticleId IdType="pubmed">32469400</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Palaiodimou L., Katsanos A.H., Caso V., K&#xf6;hrmann M., Molina C., Cordonnier C., Fischer U., Kelly P., Sharma V.K., et al. Neurological Manifestations and Implications of COVID-19 Pandemic. Ther. Adv. Neurol. Disord. 2020;13:175628642093203. doi: 10.1177/1756286420932036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286420932036</ArticleId><ArticleId IdType="pmc">PMC7284455</ArticleId><ArticleId IdType="pubmed">32565914</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Fragkou P.C., Lachanis S., Palaiodimou L., Lambadiari V., Papathanasiou M., Sfikakis P.P., Voumvourakis K.I., Tsiodras S. Olfactory Bulb and Mucosa Abnormalities in Persistent COVID-19-induced Anosmia: A Magnetic Resonance Imaging Study. Eur. J. Neurol. 2021;28:e6&#x2013;e8. doi: 10.1111/ene.14537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14537</ArticleId><ArticleId IdType="pubmed">32939911</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Fragkou P.C., Karofylakis E., Paneta M., Papathanasiou K., Palaiodimou L., Psarros C., Papathanasiou M., Lachanis S., Sfikakis P.P., et al. Hypothyroidism Is Associated with Prolonged COVID-19-Induced Anosmia: A Case&#x2013;Control Study. J. Neurol. Neurosurg. Psychiatry. 2021;92:911&#x2013;912. doi: 10.1136/jnnp-2021-326587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326587</ArticleId><ArticleId IdType="pubmed">33879534</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological Manifestations of Long-COVID Syndrome: A Narrative Review. Ther. Adv. Chronic Dis. 2022;13:204062232210768. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Neuropathophysiology of Coronavirus Disease 2019: Neuroinflammation and Blood Brain Barrier Disruption Are Critical Pathophysiological Processes That Contribute to the Clinical Symptoms of SARS-CoV-2 Infection. Inflammopharmacology. 2021;29:939&#x2013;963. doi: 10.1007/s10787-021-00806-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00806-x</ArticleId><ArticleId IdType="pmc">PMC8021940</ArticleId><ArticleId IdType="pubmed">33822324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Howard D., French L., Chen Z., Wen C., Xu Z. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in Human and Mouse Brain. BioRxiv. 2020 doi: 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan T.P., DeOre B.J., Baldwin-Leclair A., Bullock T.A., McGary H.M., Khan J.A., Razmpour R., Hale J.F., Galie P.A., Potula R., et al. The SARS-CoV-2 Spike Protein Alters Barrier Function in 2D Static and 3D Microfluidic in-Vitro Models of the Human Blood&#x2013;Brain Barrier. Neurobiol. Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A., Calvani R., Coelho-Junior H.J., Landi F., Bernabei R., Marzetti E. Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants. 2020;9:647. doi: 10.3390/antiox9080647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9080647</ArticleId><ArticleId IdType="pmc">PMC7466131</ArticleId><ArticleId IdType="pubmed">32707949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D., Antonini A., Leta V., Nordvig A., Smeyne R.J., Goldman J.E., Al-Dalahmah O., Zecca L., Sette A., Bubacco L., et al. COVID-19 and Possible Links with Parkinson&#x2019;s Disease and Parkinsonism: From Bench to Bedside. NPJ Park. Dis. 2020;6:18. doi: 10.1038/s41531-020-00123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry Z., Klenja D., Janjua N., Cami-Kobeci G., Ahmed B. COVID-19 and Parkinson&#x2019;s Disease: Shared Inflammatory Pathways Under Oxidative Stress. Brain Sci. 2020;10:807. doi: 10.3390/brainsci10110807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10110807</ArticleId><ArticleId IdType="pmc">PMC7693814</ArticleId><ArticleId IdType="pubmed">33142819</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Castro P.J., Estivill-Torr&#xfa;s G., Cabezudo-Garc&#xed;a P., Reyes-Bueno J.A., Ciano Petersen N., Aguilar-Castillo M.J., Su&#xe1;rez-P&#xe9;rez J., Jim&#xe9;nez-Hern&#xe1;ndez M.D., Moya-Molina M.&#xc1;., Oliver-Martos B., et al. Impact of SARS-CoV-2 Infection on Neurodegenerative and Neuropsychiatric Diseases: A Delayed Pandemic? Neurolog&#xed;a. 2020;35:245&#x2013;251. doi: 10.1016/j.nrl.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7164900</ArticleId><ArticleId IdType="pubmed">32364119</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A., Troiani E., Corrao S. COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review. Clin. Pract. 2020;10:1271. doi: 10.4081/cp.2020.1271.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D., Kumar V. SARS-CoV-2 Spike Protein Interactions with Amyloidogenic Proteins: Potential Clues to Neurodegeneration. Biochem. Biophys. Res. Commun. 2021;554:94&#x2013;98. doi: 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda-Rivera A.K., Cruz-Gregorio A., Pedraza-Chaverri J., Scholze A. Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls. Antioxidants. 2022;11:1112. doi: 10.3390/antiox11061112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11061112</ArticleId><ArticleId IdType="pmc">PMC9220138</ArticleId><ArticleId IdType="pubmed">35740009</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie Y., Suzuki T., Inoue J., Iso T., Wells G., Moore T.W., Mizushima T., Dinkova-Kostova A.T., Kasai T., Kamei T., et al. Molecular Basis for the Disruption of Keap1&#x2013;Nrf2 Interaction via Hinge &amp; Latch Mechanism. Commun. Biol. 2021;4:576. doi: 10.1038/s42003-021-02100-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02100-6</ArticleId><ArticleId IdType="pmc">PMC8121781</ArticleId><ArticleId IdType="pubmed">33990683</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda-Rivera A.K., Cruz-Gregorio A., Arancibia-Hern&#xe1;ndez Y.L., Hern&#xe1;ndez-Cruz E.Y., Pedraza-Chaverri J. RONS and Oxidative Stress: An Overview of Basic Concepts. Oxygen. 2022;2:437&#x2013;478. doi: 10.3390/oxygen2040030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/oxygen2040030</ArticleId></ArticleIdList></Reference><Reference><Citation>Baird L., Yamamoto M. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Mol. Cell. Biol. 2020;40:e00099-20. doi: 10.1128/MCB.00099-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00099-20</ArticleId><ArticleId IdType="pmc">PMC7296212</ArticleId><ArticleId IdType="pubmed">32284348</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D., Farahani E., Thyrsted J., Blay-Cadanet J., Herengt A., Idorn M., Hait A., Hernaez B., Knudsen A., Iversen M.B., et al. SARS-CoV2-Mediated Suppression of NRF2-Signaling Reveals Potent Antiviral and Anti-Inflammatory Activity of 4-Octyl-Itaconate and Dimethyl Fumarate. Nat. Commun. 2020;11:4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz L.-O., S&#xe1;nchez-Ramos C., Prieto-Arroyo I., Urb&#xe1;nek P., Steinbrenner H., Monsalve M. Redox Regulation of FoxO Transcription Factors. Redox Biol. 2015;6:51&#x2013;72. doi: 10.1016/j.redox.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC4511623</ArticleId><ArticleId IdType="pubmed">26184557</ArticleId></ArticleIdList></Reference><Reference><Citation>Borniquel S., Garc&#xed;a-Quint&#xe1;ns N., Valle I., Olmos Y., Wild B., Mart&#xed;nez-Granero F., Soria E., Lamas S., Monsalve M. Inactivation of Foxo3a and Subsequent Downregulation of PGC-1&#x3b1; Mediate Nitric Oxide-Induced Endothelial Cell Migration. Mol. Cell. Biol. 2010;30:4035&#x2013;4044. doi: 10.1128/MCB.00175-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00175-10</ArticleId><ArticleId IdType="pmc">PMC2916439</ArticleId><ArticleId IdType="pubmed">20547753</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Monks B., Ge Q., Birnbaum M.J. Akt/PKB Regulates Hepatic Metabolism by Directly Inhibiting PGC-1&#x3b1; Transcription Coactivator. Nature. 2007;447:1012&#x2013;1016. doi: 10.1038/nature05861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05861</ArticleId><ArticleId IdType="pubmed">17554339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Bian Q., Liu Y., Fernandes A., Taylor A., Pereira P., Shang F. Sustained Oxidative Stress Inhibits NF-&#x39a;B Activation Partially via Inactivating the Proteasome. Free Radic. Biol. Med. 2009;46:62&#x2013;69. doi: 10.1016/j.freeradbiomed.2008.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2008.09.021</ArticleId><ArticleId IdType="pmc">PMC2688728</ArticleId><ArticleId IdType="pubmed">18948189</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrzejewski K., Jampolska M., Zaremba M., Joniec-Maciejak I., Boguszewski P.M., Kaczy&#x144;ska K. Respiratory Pattern and Phrenic and Hypoglossal Nerve Activity during Normoxia and Hypoxia in 6-OHDA-Induced Bilateral Model of Parkinson&#x2019;s Disease. J. Physiol. Sci. 2020;70:16. doi: 10.1186/s12576-020-00743-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12576-020-00743-4</ArticleId><ArticleId IdType="pmc">PMC7066294</ArticleId><ArticleId IdType="pubmed">32160868</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumens R., Blokland A., Prickaerts J. Modeling Parkinson&#x2019;s Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway. Exp. Neurol. 2002;175:303&#x2013;317. doi: 10.1006/exnr.2002.7891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2002.7891</ArticleId><ArticleId IdType="pubmed">12061862</ArticleId></ArticleIdList></Reference><Reference><Citation>Glinka Y.Y., Youdim M.B.H. Inhibition of Mitochondrial Complexes I and IV by 6-Hydroxydopamine. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. 1995;292:329&#x2013;332. doi: 10.1016/0926-6917(95)90040-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0926-6917(95)90040-3</ArticleId><ArticleId IdType="pubmed">7796873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K., Ogawa N., Asanuma M. Molecular Basis of 6-Hydroxydopamine-Induced Caspase Activations Due to Increases in Oxidative Stress in the Mouse Striatum. Neurosci. Lett. 2006;410:85&#x2013;89. doi: 10.1016/j.neulet.2006.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.08.021</ArticleId><ArticleId IdType="pubmed">17092650</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirmenstein M.A., Hu C.X., Scicchitano M.S., Narayanan P.K., McFarland D.C., Thomas H.C., Schwartz L.W. Effects of 6-Hydroxydopamine on Mitochondrial Function and Glutathione Status in SH-SY5Y Human Neuroblastoma Cells. Toxicol. Vitr. 2005;19:471&#x2013;479. doi: 10.1016/j.tiv.2005.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2005.01.006</ArticleId><ArticleId IdType="pubmed">15826805</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum D., Torch S., Lambeng N., Nissou M.-F., Benabid A.-L., Sadoul R., Verna J.-M. Molecular Pathways Involved in the Neurotoxicity of 6-OHDA, Dopamine and MPTP: Contribution to the Apoptotic Theory in Parkinson&#x2019;s Disease. Prog. Neurobiol. 2001;65:135&#x2013;172. doi: 10.1016/S0301-0082(01)00003-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(01)00003-X</ArticleId><ArticleId IdType="pubmed">11403877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P., Deng F., Zhang W., Ji J., Liu J., Sun Y., Hu J. Tectorigenin Attenuates the MPP+-induced SH-SY5Y Cell Damage, Indicating a Potential Beneficial Role in Parkinson&#x2019;s Disease by Oxidative Stress Inhibition. Exp. Ther. Med. 2017;14:4431&#x2013;4437. doi: 10.3892/etm.2017.5049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.5049</ArticleId><ArticleId IdType="pmc">PMC5647714</ArticleId><ArticleId IdType="pubmed">29067118</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestuto V., Amodio G., Pepe G., Basilicata M.G., Belvedere R., Napolitano E., Guarnieri D., Pagliara V., Paladino S., Rodriquez M., et al. Cocoa Extract Provides Protection against 6-OHDA Toxicity in SH-SY5Y Dopaminergic Neurons by Targeting PERK. Biomedicines. 2022;10:2009. doi: 10.3390/biomedicines10082009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10082009</ArticleId><ArticleId IdType="pmc">PMC9405838</ArticleId><ArticleId IdType="pubmed">36009556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chansiw N., Kulprachakarn K., Paradee N., Prommaban A., Srichairatanakool S. Protection of Iron-Induced Oxidative Damage in Neuroblastoma (SH-SY5Y) Cells by Combination of 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-One and Green Tea Extract. Bioinorg. Chem. Appl. 2021;2021:5539666. doi: 10.1155/2021/5539666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5539666</ArticleId><ArticleId IdType="pmc">PMC8079199</ArticleId><ArticleId IdType="pubmed">33986790</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Kanthasamy A.G., Reddy M.B. EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model. Park. Dis. 2015;2015:843906. doi: 10.1155/2015/843906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/843906</ArticleId><ArticleId IdType="pmc">PMC4684886</ArticleId><ArticleId IdType="pubmed">26770869</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenza G.L. HIF-1: Mediator of Physiological and Pathophysiological Responses to Hypoxia. J. Appl. Physiol. 2000;88:1474&#x2013;1480. doi: 10.1152/jappl.2000.88.4.1474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.2000.88.4.1474</ArticleId><ArticleId IdType="pubmed">10749844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazelas P., Steichen C., Favreau F., Trouillas P., Hannaert P., Thuillier R., Giraud S., Hauet T., Guillard J. Oxidative Stress Evaluation in Ischemia Reperfusion Models: Characteristics, Limits and Perspectives. IJMS. 2021;22:2366. doi: 10.3390/ijms22052366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052366</ArticleId><ArticleId IdType="pmc">PMC7956779</ArticleId><ArticleId IdType="pubmed">33673423</ArticleId></ArticleIdList></Reference><Reference><Citation>Irani K. Oxidant Signaling in Vascular Cell Growth, Death, and Survival: A Review of the Roles of Reactive Oxygen Species in Smooth Muscle and Endothelial Cell Mitogenic and Apoptotic Signaling. Circ. Res. 2000;87:179&#x2013;183. doi: 10.1161/01.RES.87.3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.3.179</ArticleId><ArticleId IdType="pubmed">10926866</ArticleId></ArticleIdList></Reference><Reference><Citation>Saikumar P., Dong Z., Weinberg J.M., Venkatachalam M.A. Mechanisms of Cell Death in Hypoxia/Reoxygenation Injury. Oncogene. 1998;17:3341&#x2013;3349. doi: 10.1038/sj.onc.1202579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1202579</ArticleId><ArticleId IdType="pubmed">9916996</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C., Westenberger A. Genetics of Parkinson&#x2019;s Disease. Cold Spring Harb. Perspect. Med. 2012;2:a008888. doi: 10.1101/cshperspect.a008888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a008888</ArticleId><ArticleId IdType="pmc">PMC3253033</ArticleId><ArticleId IdType="pubmed">22315721</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin I., Dawson V.L., Dawson T.M. Recent Advances in the Genetics of Parkinson&#x2019;s Disease. Annu. Rev. Genom. Hum. Genet. 2011;12:301&#x2013;325. doi: 10.1146/annurev-genom-082410-101440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-082410-101440</ArticleId><ArticleId IdType="pmc">PMC4120236</ArticleId><ArticleId IdType="pubmed">21639795</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott L., Dawson V.L., Dawson T.M. Trumping Neurodegeneration: Targeting Common Pathways Regulated by Autosomal Recessive Parkinson&#x2019;s Disease Genes. Exp. Neurol. 2017;298:191&#x2013;201. doi: 10.1016/j.expneurol.2017.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.04.008</ArticleId><ArticleId IdType="pmc">PMC5653467</ArticleId><ArticleId IdType="pubmed">28445716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittner L.M., Halliday G.M., Kril J.J., G&#xf6;tz J., Hodges J.R., Kiernan M.C. FTD and ALS&#x2014;Translating Mouse Studies into Clinical Trials. Nat. Rev. Neurol. 2015;11:360&#x2013;366. doi: 10.1038/nrneurol.2015.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.65</ArticleId><ArticleId IdType="pubmed">25939274</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C., Strooper B.D. The Presenilins in Alzheimer&#x2019;s Disease--Proteolysis Holds the Key. Science. 1999;286:916&#x2013;919. doi: 10.1126/science.286.5441.916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5441.916</ArticleId><ArticleId IdType="pubmed">10542139</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson T.M., Golde T.E., Lagier-Tourenne C. Animal Models of Neurodegenerative Diseases. Nat. Neurosci. 2018;21:1370&#x2013;1379. doi: 10.1038/s41593-018-0236-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0236-8</ArticleId><ArticleId IdType="pmc">PMC6615039</ArticleId><ArticleId IdType="pubmed">30250265</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson T.E., de Castro E., Hegi de Castro S., Cypser J., Henderson S., Tedesco P. Relationship between Increased Longevity and Stress Resistance as Assessed through Gerontogene Mutations in Caenorhabditis Elegans. Exp. Gerontol. 2001;36:1609&#x2013;1617. doi: 10.1016/S0531-5565(01)00144-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(01)00144-9</ArticleId><ArticleId IdType="pubmed">11672983</ArticleId></ArticleIdList></Reference><Reference><Citation>Melov S. Animal Models of Oxidative Stress, Aging, and Therapeutic Antioxidant Interventions. Int. J. Biochem. Cell Biol. 2002;34:1395&#x2013;1400. doi: 10.1016/S1357-2725(02)00086-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1357-2725(02)00086-9</ArticleId><ArticleId IdType="pubmed">12200034</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen P.L. Aging and Resistance to Oxidative Damage in Caenorhabditis Elegans. Proc. Natl. Acad. Sci. USA. 1993;90:8905&#x2013;8909. doi: 10.1073/pnas.90.19.8905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.19.8905</ArticleId><ArticleId IdType="pmc">PMC47469</ArticleId><ArticleId IdType="pubmed">8415630</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson T.E. Increased Life-Span of Age-1 Mutants in Caenorhabditis Elegans and Lower Gompertz Rate of Aging. Science. 1990;249:908&#x2013;912. doi: 10.1126/science.2392681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2392681</ArticleId><ArticleId IdType="pubmed">2392681</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.-C., Liu K.-F., Teng C.-J., Lai S.-C., Yang S.-E., Ching H., Wu C.-R. Sophora Tomentosa Extract Prevents MPTP-Induced Parkinsonism in C57BL/6 Mice Via the Inhibition of GSK-3&#x3b2; Phosphorylation and Oxidative Stress. Nutrients. 2019;11:252. doi: 10.3390/nu11020252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020252</ArticleId><ArticleId IdType="pmc">PMC6412387</ArticleId><ArticleId IdType="pubmed">30678114</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic Systemic Pesticide Exposure Reproduces Features of Parkinson&#x2019;s Disease. Nat. Neurosci. 2000;3:1301&#x2013;1306. doi: 10.1038/81834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/81834</ArticleId><ArticleId IdType="pubmed">11100151</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Tiffany-Castiglioni E., Lee M.-Y., Son I.-H. Paraquat Induces Cyclooxygenase-2 (COX-2) Implicated Toxicity in Human Neuroblastoma SH-SY5Y Cells. Toxicol. Lett. 2010;199:239&#x2013;246. doi: 10.1016/j.toxlet.2010.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2010.09.005</ArticleId><ArticleId IdType="pubmed">20851755</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M., Angelov B., Garamus V.M., Angelova A. Curcumin- and Fish Oil-Loaded Spongosome and Cubosome Nanoparticles with Neuroprotective Potential against H2O2-Induced Oxidative Stress in Differentiated Human SH-SY5Y Cells. ACS Omega. 2019;4:3061&#x2013;3073. doi: 10.1021/acsomega.8b03101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.8b03101</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransy C., Vaz C., Lomb&#xe8;s A., Bouillaud F. Use of H2O2 to Cause Oxidative Stress, the Catalase Issue. IJMS. 2020;21:9149. doi: 10.3390/ijms21239149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21239149</ArticleId><ArticleId IdType="pmc">PMC7731207</ArticleId><ArticleId IdType="pubmed">33266350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S.-H., Lee S.R., Park Y.J., Ra M., Lee Y., Pang C., Kim K.H. Suppression of 6-Hydroxydopamine-Induced Oxidative Stress by Hyperoside Via Activation of Nrf2/HO-1 Signaling in Dopaminergic Neurons. IJMS. 2019;20:5832. doi: 10.3390/ijms20235832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20235832</ArticleId><ArticleId IdType="pmc">PMC6929192</ArticleId><ArticleId IdType="pubmed">31757050</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate Toxicity in a Neuronal Cell Line Involves Inhibition of Cystine Transport Leading to Oxidative Stress. Neuron. 1989;2:1547&#x2013;1558. doi: 10.1016/0896-6273(89)90043-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(89)90043-3</ArticleId><ArticleId IdType="pubmed">2576375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sali&#x144;ska E., Danysz W., &#x141;azarewicz J.W. The Role of Excitotoxicity in Neurodegeneration. Folia Neuropathol. 2005;43:322&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">16416396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Kalonia H., Kumar A. Novel Protective Mechanisms of Antidepressants against 3-Nitropropionic Acid Induced Huntington&#x2019;s-like Symptoms: A Comparative Study. J. Psychopharmacol. 2011;25:1399&#x2013;1411. doi: 10.1177/0269881110364269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881110364269</ArticleId><ArticleId IdType="pubmed">20305041</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi A., Patki G., Khan E., Asghar M., Salim S. Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells. Oxidative Med. Cell. Longev. 2016;2016:5059043. doi: 10.1155/2016/5059043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5059043</ArticleId><ArticleId IdType="pmc">PMC4812466</ArticleId><ArticleId IdType="pubmed">27069531</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotoarisoa M., Angelov B., Drechsler M., Nicolas V., Bizien T., Gorshkova Y.E., Deng Y., Angelova A. Liquid Crystalline Lipid Nanoparticles for Combined Delivery of Curcumin, Fish Oil and BDNF: In Vitro Neuroprotective Potential in a Cellular Model of Tunicamycin-Induced Endoplasmic Reticulum Stress. Smart Mater. Med. 2022;3:274&#x2013;288. doi: 10.1016/j.smaim.2022.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smaim.2022.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin I., Jones M.A., Rhodenizer D., Zheng J., Warrick J.M., Seroude L., Grotewiel M. Sod2 Knockdown in the Musculature Has Whole-Organism Consequences in Drosophila. Free Radic. Biol. Med. 2009;47:803&#x2013;813. doi: 10.1016/j.freeradbiomed.2009.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.06.021</ArticleId><ArticleId IdType="pmc">PMC2739907</ArticleId><ArticleId IdType="pubmed">19545620</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak A., Kojder K., Zielonka-Brzezicka J., Wr&#xf3;bel J., Bosiacki M., Fabia&#x144;ska M., Wr&#xf3;bel M., So&#x142;ek-Pastuszka J., Klimowicz A. The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer&#x2019;s Disease. Front. Pharmacol. 2021;12:775034. doi: 10.3389/fphar.2021.775034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.775034</ArticleId><ArticleId IdType="pmc">PMC8599153</ArticleId><ArticleId IdType="pubmed">34803717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley P.R., editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs. British Herbal Medicine Association; Bournemouth, UK: 1992.</Citation></Reference><Reference><Citation>Yang Y., Liu P., Chen L., Liu Z., Zhang H., Wang J., Sun X., Zhong W., Wang N., Tian K., et al. Therapeutic Effect of Ginkgo Biloba Polysaccharide in Rats with Focal Cerebral Ischemia/Reperfusion (I/R) Injury. Carbohydr. Polym. 2013;98:1383&#x2013;1388. doi: 10.1016/j.carbpol.2013.07.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2013.07.045</ArticleId><ArticleId IdType="pubmed">24053818</ArticleId></ArticleIdList></Reference><Reference><Citation>Achete de Souza G., de Marqui S.V., Matias J.N., Guiguer E.L., Barbalho S.M. Effects of Ginkgo Biloba on Diseases Related to Oxidative Stress. Planta Med. 2020;86:376&#x2013;386. doi: 10.1055/a-1109-3405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1109-3405</ArticleId><ArticleId IdType="pubmed">32097975</ArticleId></ArticleIdList></Reference><Reference><Citation>Trebatick&#xe1; J., &#x10e;ura&#x10d;kov&#xe1; Z. Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy? Oxidative Med. Cell. Longev. 2015;2015:248529. doi: 10.1155/2015/248529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/248529</ArticleId><ArticleId IdType="pmc">PMC4477218</ArticleId><ArticleId IdType="pubmed">26180581</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik J., Choudhary S., Kumar P. Plants and Phytochemicals for Huntington&#x2032;s Disease. Pharmacogn. Rev. 2013;7:81. doi: 10.4103/0973-7847.120505.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0973-7847.120505</ArticleId><ArticleId IdType="pmc">PMC3841999</ArticleId><ArticleId IdType="pubmed">24347915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Lu Y., Qian Y., Chen B., Wu T., Ji G. Recent Progress Regarding Kaempferol for the Treatment of Various Diseases (Review) Exp. Ther. Med. 2019;18:2759&#x2013;2776. doi: 10.3892/etm.2019.7886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7886</ArticleId><ArticleId IdType="pmc">PMC6755486</ArticleId><ArticleId IdType="pubmed">31572524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Ren H., Han J., Wang W., Zheng Q., Wang D. Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3 &#x3b2;. Oxidative Med. Cell. Longev. 2015;2015:481405. doi: 10.1155/2015/481405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/481405</ArticleId><ArticleId IdType="pmc">PMC4525766</ArticleId><ArticleId IdType="pubmed">26265983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C.-C., Hsiao L.-D., Wang C.-Y., Lin W.-N., Shih Y.-F., Chen Y.-W., Cho R.-L., Tseng H.-C., Yang C.-M. HO-1 Upregulation by Kaempferol via ROS-Dependent Nrf2-ARE Cascade Attenuates Lipopolysaccharide-Mediated Intercellular Cell Adhesion Molecule-1 Expression in Human Pulmonary Alveolar Epithelial Cells. Antioxidants. 2022;11:782. doi: 10.3390/antiox11040782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11040782</ArticleId><ArticleId IdType="pmc">PMC9028455</ArticleId><ArticleId IdType="pubmed">35453467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L.J., Zhu X.Z. Reactive Oxygen Species-Induced Apoptosis in PC12 Cells and Protective Effect of Bilobalide. J. Pharmacol. Exp. Ther. 2000;293:982&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T., Lv L., Yu Y., Jia L., Song X., Xu X., Li T., Sheng X., Wang H., Zhang J., et al. Bilobalide Exerts Anti-Inflammatory Effects on Chondrocytes Through the AMPK/SIRT1/MTOR Pathway to Attenuate ACLT-Induced Post-Traumatic Osteoarthritis in Rats. Front. Pharmacol. 2022;13:783506. doi: 10.3389/fphar.2022.783506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.783506</ArticleId><ArticleId IdType="pmc">PMC8905364</ArticleId><ArticleId IdType="pubmed">35281931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Huang J., Li J., Chen K., Zhang X., Zhang Y., Zhu Y. Bilobalide, a Bioactive Compound on Sepsis-Induced Acute Lung Injury through Its Anti-Inflammatory and Antioxidative Activity. Pharmacogn. Mag. 2021;17:163. doi: 10.4103/pm.pm_448_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/pm.pm_448_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchantchou F., Lacor P.N., Cao Z., Lao L., Hou Y., Cui C., Klein W.L., Luo Y. Stimulation of Neurogenesis and Synaptogenesis by Bilobalide and Quercetin via Common Final Pathway in Hippocampal Neurons. JAD. 2009;18:787&#x2013;798. doi: 10.3233/JAD-2009-1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2009-1189</ArticleId><ArticleId IdType="pubmed">19661619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J.-M., Gu S.-S., Mei W.H., Zhou J., Wang Z.Z., Xiao W. Ginkgolides and Bilobalide Protect BV2 Microglia Cells against OGD/Reoxygenation Injury by Inhibiting TLR2/4 Signaling Pathways. Cell Stress Chaperones. 2016;21:1037&#x2013;1053. doi: 10.1007/s12192-016-0728-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-016-0728-y</ArticleId><ArticleId IdType="pmc">PMC5083673</ArticleId><ArticleId IdType="pubmed">27562518</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Qu P. Effects of Ginkgo Biloba Leaf Extract on Local Renin-Angiotensin System through TLR4/NF-&#x39a;B Pathway in Cardiac Myocyte. Exp. Ther. Med. 2017;14:5857&#x2013;5862. doi: 10.3892/etm.2017.5313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.5313</ArticleId><ArticleId IdType="pmc">PMC5740758</ArticleId><ArticleId IdType="pubmed">29285133</ArticleId></ArticleIdList></Reference><Reference><Citation>He G., Yuan C., Hao L., Xu Y., Zhang Z. GBE50 Attenuates Inflammatory Response by Inhibiting the P38 MAPK and NF-&#x3ba;B Pathways in LPS-Stimulated Microglial Cells. Evid. Based Complement. Altern. Med. 2014;2014:368598. doi: 10.1155/2014/368598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/368598</ArticleId><ArticleId IdType="pmc">PMC3982279</ArticleId><ArticleId IdType="pubmed">24782908</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F.-Q., Gao Q., Wang D.-D., Zhang Z.-X. Effects of GBE50 on LPS/ATP induced NLRP3 inflammasome activation in primary rat microglia. China J. Chin. Mater. Med. 2018;43:3346&#x2013;3352. doi: 10.19540/j.cnki.cjcmm.20180504.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.19540/j.cnki.cjcmm.20180504.001</ArticleId><ArticleId IdType="pubmed">30200740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong G., Guan Y.-Y., Zhang Z.-L., Rahman K., Wang S.-J., Zhou S., Luan X., Zhang H. Isorhamnetin: A Review of Pharmacological Effects. Biomed. Pharmacother. 2020;128:110301. doi: 10.1016/j.biopha.2020.110301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110301</ArticleId><ArticleId IdType="pubmed">32502837</ArticleId></ArticleIdList></Reference><Reference><Citation>Derosa G., Maffioli P., D&#x2019;Angelo A., Di Pierro F. A Role for Quercetin in Coronavirus Disease 2019 (COVID-19) Phytother. Res. 2021;35:1230&#x2013;1236. doi: 10.1002/ptr.6887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6887</ArticleId><ArticleId IdType="pmc">PMC7675685</ArticleId><ArticleId IdType="pubmed">33034398</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Jin Z., Xu Z., Yang H., Li L., Li G., Li F., Gu S., Zong S., Zhou J., et al. Antioxidant Effects of Ginkgolides and Bilobalide against Cerebral Ischemia Injury by Activating the Akt/Nrf2 Pathway in Vitro and in Vivo. Cell Stress Chaperones. 2019;24:441&#x2013;452. doi: 10.1007/s12192-019-00977-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-019-00977-1</ArticleId><ArticleId IdType="pmc">PMC6439064</ArticleId><ArticleId IdType="pubmed">30815818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur N., Dhiman M., Perez-Polo J.R., Mantha A.K. Ginkgolide B Revamps Neuroprotective Role of Apurinic/Apyrimidinic Endonuclease 1 and Mitochondrial Oxidative Phosphorylation against A&#x3b2; 25-35 -Induced Neurotoxicity in Human Neuroblastoma Cells: Neuroprotective Role of APE1. J. Neurosci. Res. 2015;93:938&#x2013;947. doi: 10.1002/jnr.23565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23565</ArticleId><ArticleId IdType="pubmed">25677400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H., Guo X., Zhang S., Dial S.L., Guo L., Manjanatha M.G., Moore M.M., Mei N. Mechanistic Evaluation of Ginkgo Biloba Leaf Extract-Induced Genotoxicity in L5178Y Cells. Toxicol. Sci. 2014;139:338&#x2013;349. doi: 10.1093/toxsci/kfu037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfu037</ArticleId><ArticleId IdType="pmc">PMC8142259</ArticleId><ArticleId IdType="pubmed">24595819</ArticleId></ArticleIdList></Reference><Reference><Citation>Parimoo H.A., Sharma R., Patil R.D., Sharma O.P., Kumar P., Kumar N. Hepatoprotective Effect of Ginkgo Biloba Leaf Extract on Lantadenes-Induced Hepatotoxicity in Guinea Pigs. Toxicon. 2014;81:1&#x2013;12. doi: 10.1016/j.toxicon.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2014.01.013</ArticleId><ArticleId IdType="pubmed">24472344</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q., Wang C., Li J., Hou Q., Li J., Ma J., Wang W., Wang Z. Ginkgolide B Protects Hippocampal Neurons from Apoptosis Induced by Beta-Amyloid 25&#x2013;35 Partly via up-Regulation of Brain-Derived Neurotrophic Factor. Eur. J. Pharmacol. 2010;647:48&#x2013;54. doi: 10.1016/j.ejphar.2010.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2010.08.002</ArticleId><ArticleId IdType="pubmed">20709055</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou C.-J., Lai X.-Y., Chen Y.-L., Wang C.-L., Wei C.-H., Huang W.-C. Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway. Evid. Based Complement. Altern. Med. 2015;2015:298635. doi: 10.1155/2015/298635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/298635</ArticleId><ArticleId IdType="pmc">PMC4568043</ArticleId><ArticleId IdType="pubmed">26413119</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.-C., Chen Y.-L., Liu H.-C., Wu S.-J., Liou C.-J. Ginkgolide C Reduced Oleic Acid-Induced Lipid Accumulation in HepG2 Cells. Saudi Pharm. J. 2018;26:1178&#x2013;1184. doi: 10.1016/j.jsps.2018.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsps.2018.07.006</ArticleId><ArticleId IdType="pmc">PMC6260475</ArticleId><ArticleId IdType="pubmed">30532639</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Han D., Li Z., Shen C., Zhang Y., Li J., Yan G., Li S., Hu B., Li J., et al. Ginkgolide C Alleviates Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Inhibition of CD40-NF-&#x39a;B Pathway. Front. Pharmacol. 2018;9:109. doi: 10.3389/fphar.2018.00109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00109</ArticleId><ArticleId IdType="pmc">PMC5826377</ArticleId><ArticleId IdType="pubmed">29515442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Qin J., Shen W., Wu A. Bilobalide Enhances AMPK Activity to Improve Liver Injury and Metabolic Disorders in STZ-Induced Diabetes in Immature Rats via Regulating HMGB1/TLR4/NF-&#x39a;B Signaling Pathway. BioMed Res. Int. 2021;2021:8835408. doi: 10.1155/2021/8835408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8835408</ArticleId><ArticleId IdType="pmc">PMC8075671</ArticleId><ArticleId IdType="pubmed">33959665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Wang S., Fu L., Liu D., Zhu Y., Xu A. Bilobalide Protection of Normal Human Melanocytes from Hydrogen Peroxide-Induced Oxidative Damage via Promotion of Antioxidase Expression and Inhibition of Endoplasmic Reticulum Stress. Clin. Exp. Dermatol. 2016;41:64&#x2013;73. doi: 10.1111/ced.12664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ced.12664</ArticleId><ArticleId IdType="pubmed">26178968</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Garc&#xed;a N., Pedraza-Chaverri J., Mares-S&#xe1;mano J.J., Orozco-Ibarra M., Cruz-Salgado A., Jim&#xe9;nez-Anguiano A., Sotelo J., Trejo-Sol&#xed;s C. Antiapoptotic Effects of EGb 761. Evid. Based Complement. Altern. Med. 2013;2013:495703. doi: 10.1155/2013/495703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/495703</ArticleId><ArticleId IdType="pmc">PMC3745884</ArticleId><ArticleId IdType="pubmed">23983787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku S.-K., Kim T.H., Bae J.-S. Anticoagulant Activities of Persicarin and Isorhamnetin. Vasc. Pharmacol. 2013;58:272&#x2013;279. doi: 10.1016/j.vph.2013.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2013.01.005</ArticleId><ArticleId IdType="pubmed">23391847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.H., Shin B.Y., Han J.Y., Kim M.G., Wi J.E., Kim Y.W., Cho I.J., Kim S.C., Shin S.M., Ki S.H. Isorhamnetin Protects against Oxidative Stress by Activating Nrf2 and Inducing the Expression of Its Target Genes. Toxicol. Appl. Pharmacol. 2014;274:293&#x2013;301. doi: 10.1016/j.taap.2013.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2013.10.026</ArticleId><ArticleId IdType="pubmed">24211276</ArticleId></ArticleIdList></Reference><Reference><Citation>Mango D., Weisz F., Nistic&#xf2; R. Ginkgolic Acid Protects against A&#x3b2;-Induced Synaptic Dysfunction in the Hippocampus. Front. Pharmacol. 2016;7:401. doi: 10.3389/fphar.2016.00401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2016.00401</ArticleId><ArticleId IdType="pmc">PMC5080287</ArticleId><ArticleId IdType="pubmed">27833555</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumaran S., Nakamura Y., Henley J.M., Pountney D.L. Ginkgolic Acid Promotes Autophagy-Dependent Clearance of Intracellular Alpha-Synuclein Aggregates. Mol. Cell. Neurosci. 2019;101:103416. doi: 10.1016/j.mcn.2019.103416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103416</ArticleId><ArticleId IdType="pubmed">31654699</ArticleId></ArticleIdList></Reference><Reference><Citation>Boots A.W., Drent M., de Boer V.C.J., Bast A., Haenen G.R.M.M. Quercetin Reduces Markers of Oxidative Stress and Inflammation in Sarcoidosis. Clin. Nutr. 2011;30:506&#x2013;512. doi: 10.1016/j.clnu.2011.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2011.01.010</ArticleId><ArticleId IdType="pubmed">21324570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Jiang H., Wu X., Fang J. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes. Mediat. Inflamm. 2016;2016:9343460. doi: 10.1155/2016/9340637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9340637</ArticleId><ArticleId IdType="pmc">PMC5149671</ArticleId><ArticleId IdType="pubmed">28003714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhang L., Zhang Y., Luo M., Wu Q., Yu L., Chu H. Transcriptional Upregulation Centra of HO-1 by EGB via the MAPKs/Nrf2 Pathway in Mouse C2C12 Myoblasts. Toxicol. Vitr. 2015;29:380&#x2013;388. doi: 10.1016/j.tiv.2014.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2014.10.015</ArticleId><ArticleId IdType="pubmed">25449124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali F., Rahul, Jyoti S., Naz F., Ashafaq M., Shahid M., Siddique Y.H. Therapeutic Potential of Luteolin in Transgenic Drosophila Model of Alzheimer&#x2019;s Disease. Neurosci. Lett. 2019;692:90&#x2013;99. doi: 10.1016/j.neulet.2018.10.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.10.053</ArticleId><ArticleId IdType="pubmed">30420334</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Shang P., Li D. Luteolin: A Flavonoid That Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms. Front. Pharmacol. 2017;8:692. doi: 10.3389/fphar.2017.00692.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00692</ArticleId><ArticleId IdType="pmc">PMC5635727</ArticleId><ArticleId IdType="pubmed">29056912</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.V., Burdick A.J., Golik P., Khan I., Wallace D., Luo Y. Anti-Apoptotic Properties of Ginkgo Biloba Extract EGb 761 in Differentiated PC12 Cells. Cell. Mol. Biol. 2002;48:699&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">12396082</ArticleId></ArticleIdList></Reference><Reference><Citation>Perianayagam M.C., Madias N.E., Pereira B.J.G., Jaber B.L. CREB Transcription Factor Modulates Bcl2 Transcription in Response to C5a in HL-60-Derived Neutrophils. Eur. J. Clin. Investig. 2006;36:353&#x2013;361. doi: 10.1111/j.1365-2362.2006.01637.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2006.01637.x</ArticleId><ArticleId IdType="pubmed">16634840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchantchou F., Xu Y., Wu Y., Christen Y., Luo Y. EGb 761 Enhances Adult Hippocampal Neurogenesis and Phosphorylation of CREB in Transgenic Mouse Model of Alzheimer&#x2019;s Disease. FASEB J. 2007;21:2400&#x2013;2408. doi: 10.1096/fj.06-7649com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-7649com</ArticleId><ArticleId IdType="pubmed">17356006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao F., Li A., Yu H., Liu M., Wang Y., Liu J., Liang Z. Enhanced Neuroprotective Effects of Combination Therapy with Bone Marrow-Derived Mesenchymal Stem Cells and Ginkgo Biloba Extract (EGb761) in a Rat Model of Experimental Autoimmune Encephalomyelitis. Neuroimmunomodulation. 2016;23:41&#x2013;57. doi: 10.1159/000437429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000437429</ArticleId><ArticleId IdType="pubmed">26468875</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Wang X., Geng M. Alzheimer&#x2019;s Disease Hypothesis and Related Therapies. Transl. Neurodegener. 2018;7:2. doi: 10.1186/s40035-018-0107-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0107-y</ArticleId><ArticleId IdType="pmc">PMC5789526</ArticleId><ArticleId IdType="pubmed">29423193</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson U. The Cholinergic Anti-Inflammatory Pathway Alleviates Acute Lung Injury. Mol. Med. 2020;26:64. doi: 10.1186/s10020-020-00184-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-020-00184-0</ArticleId><ArticleId IdType="pmc">PMC7322708</ArticleId><ArticleId IdType="pubmed">32600316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivic L., Sands T.T.J., Fishkin N., Nakanishi K., Kriegstein A.R., Str&#xf8;mgaard K. Terpene Trilactones from Ginkgo Biloba Are Antagonists of Cortical Glycine and GABAA Receptors. J. Biol. Chem. 2003;278:49279&#x2013;49285. doi: 10.1074/jbc.M304034200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M304034200</ArticleId><ArticleId IdType="pubmed">14504293</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandris N., Lagoumintzis G., Chasapis C.T., Leonidas D.D., Papadopoulos G.E., Tzartos S.J., Tsatsakis A., Eliopoulos E., Poulas K., Farsalinos K. Nicotinic Cholinergic System and COVID-19: In Silico Evaluation of Nicotinic Acetylcholine Receptor Agonists as Potential Therapeutic Interventions. Toxicol. Rep. 2021;8:73&#x2013;83. doi: 10.1016/j.toxrep.2020.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxrep.2020.12.013</ArticleId><ArticleId IdType="pmc">PMC7776751</ArticleId><ArticleId IdType="pubmed">33425684</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegel R., Kalla R., Mantokoudis G., Maire R., Mueller H., Hoerr R., Ihl R. Ginkgo Biloba Extract EGb 761&amp;reg; Alleviates Neurosensory Symptoms in Patients with Dementia: A Meta-Analysis of Treatment Effects on Tinnitus and Dizziness in Randomized, Placebo-Controlled Trials. CIA. 2018;13:1121&#x2013;1127. doi: 10.2147/CIA.S157877.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S157877</ArticleId><ArticleId IdType="pmc">PMC6005330</ArticleId><ArticleId IdType="pubmed">29942120</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Meo F., Cuciniello R., Margarucci S., Bergamo P., Petillo O., Peluso G., Filosa S., Crispi S. Ginkgo Biloba Prevents Oxidative Stress-Induced Apoptosis Blocking P53 Activation in Neuroblastoma Cells. Antioxidants. 2020;9:279. doi: 10.3390/antiox9040279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9040279</ArticleId><ArticleId IdType="pmc">PMC7222193</ArticleId><ArticleId IdType="pubmed">32224984</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.P., Zhang X.Y., Liu N., Ma Z.Z., Fang D.S. Comparison of Integrated Traditional Chinese and Western Medicine Therapy on Vascular Cognitive Impairment with No Dementia. Genet. Mol. Res. 2015;14:4896&#x2013;4902. doi: 10.4238/2015.May.11.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/2015.May.11.22</ArticleId><ArticleId IdType="pubmed">25966264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gschwind Y.J., Bridenbaugh S.A., Reinhard S., Granacher U., Monsch A.U., Kressig R.W. Ginkgo Biloba Special Extract LI 1370 Improves Dual-Task Walking in Patients with MCI: A Randomised, Double-Blind, Placebo-Controlled Exploratory Study. Aging Clin. Exp. Res. 2017;29:609&#x2013;619. doi: 10.1007/s40520-016-0699-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-016-0699-y</ArticleId><ArticleId IdType="pmc">PMC5533811</ArticleId><ArticleId IdType="pubmed">28181206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo L.-C., Song Y.-Q., Yao C.-A., Cheng I.H., Chien C.-T., Lee G.-C., Yang W.-C., Lin Y. Ginkgolide A Prevents the Amyloid-&#x3b2;-Induced Depolarization of Cortical Neurons. J. Agric. Food Chem. 2019;67:81&#x2013;89. doi: 10.1021/acs.jafc.8b04514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.8b04514</ArticleId><ArticleId IdType="pubmed">30541279</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D., Zhang P., Li J., Liu T., Zhang Y., Wang Q., Zhang J., Lu X., Fan X. Neuroprotective Effects of Ginkgo Biloba Dropping Pills in Parkinson&#x2019;s Disease. J. Pharm. Anal. 2021;11:220&#x2013;231. doi: 10.1016/j.jpha.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC8116202</ArticleId><ArticleId IdType="pubmed">34012698</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindowski K., Leutner S., Kressmann S., Eckert A., M&#xfc;ller W.E. Age-Related Increase of Oxidative Stress-Induced Apoptosis in MicePrevention by Ginkgo Biloba Extract (EGb761) J. Neural Transm. 2001;108:969&#x2013;978. doi: 10.1007/s007020170016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007020170016</ArticleId><ArticleId IdType="pubmed">11716149</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C., Xiao S., Liu J., Guo K., Wu F., Yew D.T., Xu J. Ginkgo Biloba Extract EGb761 Protects against Aging-Associated Mitochondrial Dysfunction in Platelets and Hippocampi of SAMP8 Mice. Platelets. 2010;21:373&#x2013;379. doi: 10.3109/09537100903511448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537100903511448</ArticleId><ArticleId IdType="pubmed">20459350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.-Q., Wang M.-Y., Fu X.-R., Peng-Yu, Gao G.-F., Fan Y.-M., Duan X.-L., Zhao B.-L., Chang Y.-Z., Shi Z.-H. Neuroprotective Effects of Ginkgetin against Neuroinjury in Parkinson&#x2019;s Disease Model Induced by MPTP via Chelating Iron. Free Radic. Res. 2015;49:1069&#x2013;1080. doi: 10.3109/10715762.2015.1032958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2015.1032958</ArticleId><ArticleId IdType="pubmed">25968939</ArticleId></ArticleIdList></Reference><Reference><Citation>You O.H., Kim S.-H., Kim B., Sohn E.J., Lee H.-J., Shim B.-S., Yun M., Kwon B.-M., Kim S.-H. Ginkgetin Induces Apoptosis via Activation of Caspase and Inhibition of Survival Genes in PC-3 Prostate Cancer Cells. Bioorganic Med. Chem. Lett. 2013;23:2692&#x2013;2695. doi: 10.1016/j.bmcl.2013.02.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2013.02.080</ArticleId><ArticleId IdType="pubmed">23523142</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhein V., Giese M., Baysang G., Meier F., Rao S., Schulz K.L., Hamburger M., Eckert A. Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues A&#x3b2;-Induced Failure. PLoS ONE. 2010;5:e12359. doi: 10.1371/journal.pone.0012359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012359</ArticleId><ArticleId IdType="pmc">PMC2927422</ArticleId><ArticleId IdType="pubmed">20808761</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo O.G., Asiwe J.N., Ben-Azu B., Aduema W., Onyeleonu I., Akpotu A.E., Wopara I., Kolawole T.A., Umoren E.B., Igbokwe V., et al. Ginkgo Biloba Protects Striatal Neurodegeneration and Gut Phagoinflammatory Damage in Rotenone-induced Mice Model of Parkinson&#x2019;s Disease: Role of Executioner Caspase-3/Nrf2/ ARE Signaling. J. Food Biochem. 2022;46:e14253. doi: 10.1111/jfbc.14253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfbc.14253</ArticleId><ArticleId IdType="pubmed">35608987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z.-H., Zhang C.-Y., Pu B.-H. Effects of ginkgo biloba tablet in treating mild cognitive impairment. Chin. J. Integr. Tradit. West. Med. 2012;32:1208&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">23185760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdy H.M., Tadros M.G., Mohamed M.R., Karim A.M., Khalifa A.E. The Effect of Ginkgo Biloba Extract on 3-Nitropropionic Acid-Induced Neurotoxicity in Rats. Neurochem. Int. 2011;59:770&#x2013;778. doi: 10.1016/j.neuint.2011.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2011.07.012</ArticleId><ArticleId IdType="pubmed">21827809</ArticleId></ArticleIdList></Reference><Reference><Citation>Beg T., Jyoti S., Naz F., Rahul, Ali F., Ali S.K., Reyad A.M., Siddique Y.H. Protective Effect of Kaempferol on the Transgenic Drosophila Model of Alzheimer&#x2019;s Disease. CNS Neurol. Disord. Drug Targets. 2018;17:421&#x2013;429. doi: 10.2174/1871527317666180508123050.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527317666180508123050</ArticleId><ArticleId IdType="pubmed">29745345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Li J., Peng Q., Liu Y., Liu W., Luo C., Peng J., Li J., Yung K.K.L., Mo Z. Neuroprotective Effects of Bilobalide on Cerebral Ischemia and Reperfusion Injury Are Associated with Inhibition of Pro-Inflammatory Mediator Production and down-Regulation of JNK1/2 and P38 MAPK Activation. J. Neuroinflamm. 2014;11:167. doi: 10.1186/s12974-014-0167-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-014-0167-6</ArticleId><ArticleId IdType="pmc">PMC4189683</ArticleId><ArticleId IdType="pubmed">25256700</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Chen Z., Yan M., He P., Chen Z., Dai H. The Protective Role of Isorhamnetin on Human Brain Microvascular Endothelial Cells from Cytotoxicity Induced by Methylglyoxal and Oxygen-Glucose Deprivation. J. Neurochem. 2016;136:651&#x2013;659. doi: 10.1111/jnc.13436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13436</ArticleId><ArticleId IdType="pubmed">26578299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung J.-H., Shah F.-A., Cho E.-H., Gim S.-A., Jeon S.-J., Kim K.-M., Kim Y.-M., Kim M.-O., Koh P.-O. Ginkgo Biloba Extract (EGb 761) Prevents the Ischemic Brain Injury-Induced Decrease in Parvalbumin Expression. Lab. Anim. Res. 2012;28:77. doi: 10.5625/lar.2012.28.2.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.5625/lar.2012.28.2.77</ArticleId><ArticleId IdType="pmc">PMC3389842</ArticleId><ArticleId IdType="pubmed">22787480</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Shi Y., Zhao L. Ginkgolide B Alleviates Learning and Memory Impairment in Rats With Vascular Dementia by Reducing Neuroinflammation via Regulating NF-&#x39a;B Pathway. Front. Pharmacol. 2021;12:676392. doi: 10.3389/fphar.2021.676392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.676392</ArticleId><ArticleId IdType="pmc">PMC8245850</ArticleId><ArticleId IdType="pubmed">34220511</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Qinghai S., Kai L., Xue M., Lili N., Jihua R., Zhengxiang L., Xiaoling L., Di G., Qi Y., et al. Oral Administration of Ginkgolide B Alleviates Hypoxia-Induced Neuronal Damage in Rat Hippocampus by Inhibiting Oxidative Stress and Apoptosis. Iran. J. Basic Med. Sci. 2019;22:140&#x2013;145. doi: 10.22038/ijbms.2018.26228.6569.</Citation><ArticleIdList><ArticleId IdType="doi">10.22038/ijbms.2018.26228.6569</ArticleId><ArticleId IdType="pmc">PMC6396993</ArticleId><ArticleId IdType="pubmed">30834078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Lei Q., Zhao S., Xu W., Dong W., Ran J., Shi Q., Fu J. Ginkgolide B Maintains Calcium Homeostasis in Hypoxic Hippocampal Neurons by Inhibiting Calcium Influx and Intracellular Calcium Release. Front. Cell. Neurosci. 2021;14:627846. doi: 10.3389/fncel.2020.627846.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.627846</ArticleId><ArticleId IdType="pmc">PMC7928385</ArticleId><ArticleId IdType="pubmed">33679323</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan P.-C., Xia Q., Fu P.P. Ginkgo Biloba Leave Extract: Biological, Medicinal, and Toxicological Effects. J. Environ. Sci. Health Part C. 2007;25:211&#x2013;244. doi: 10.1080/10590500701569414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10590500701569414</ArticleId><ArticleId IdType="pubmed">17763047</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Yahya A.A., Al-Majed A.A., Al-Bekairi A.M., Al-Shabanah O.A., Qureshi S. Studies on the Reproductive, Cytological and Biochemical Toxicity of Ginkgo Biloba in Swiss Albino Mice. J. Ethnopharmacol. 2006;107:222&#x2013;228. doi: 10.1016/j.jep.2006.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2006.03.014</ArticleId><ArticleId IdType="pubmed">16624513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bent S., Goldberg H., Padula A., Avins A.L. Spontaneous Bleeding Associated with Ginkgo Biloba: A Case Report and Systematic Review of the Literature: A Case Report and Systematic Review of the Literature. J. Gen. Intern. Med. 2005;20:657&#x2013;661. doi: 10.1007/s11606-005-0114-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-005-0114-4</ArticleId><ArticleId IdType="pmc">PMC1490168</ArticleId><ArticleId IdType="pubmed">16050865</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroso J.L., Henriques Aquino C.C., Esc&#xf3;rcio Bezerra M.L., Baiense R.F., Suarez M.M., Dutra L.A., Braga-Neto P., Povoas Barsottini O.G. Ginkgo Biloba and Cerebral Bleeding: A Case Report and Critical Review. Neurologist. 2011;17:89&#x2013;90. doi: 10.1097/NRL.0b013e3181f097b4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NRL.0b013e3181f097b4</ArticleId><ArticleId IdType="pubmed">21364361</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblatt M., Mindel J. Spontaneous Hyphema Associated with Ingestion of Ginkgo Biloba Extract. N. Engl. J. Med. 1997;336:1108. doi: 10.1056/NEJM199704103361518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199704103361518</ArticleId><ArticleId IdType="pubmed">9091822</ArticleId></ArticleIdList></Reference><Reference><Citation>Oken B.S., Storzbach D.M., Kaye J.A. The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer Disease. Arch. Neurol. 1998;55:1409. doi: 10.1001/archneur.55.11.1409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.55.11.1409</ArticleId><ArticleId IdType="pubmed">9823823</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Su L., Cui H., Ren J., Li C. Ginkgo Biloba Extract for Dementia: A Systematic Review. Shanghai Arch Psychiatry. 2013;25:10&#x2013;21. doi: 10.3969/j.issn.1002-0829.2013.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1002-0829.2013.01.005</ArticleId><ArticleId IdType="pmc">PMC4054525</ArticleId><ArticleId IdType="pubmed">24991128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal Dit Sollier C., Caplain H., Drouet L. No Alteration in Platelet Function or Coagulation Induced by EGb761 in a Controlled Study: No Effect of Egb761 on Platelet and Coagulation. Clin. Lab. Haematol. 2003;25:251&#x2013;253. doi: 10.1046/j.1365-2257.2003.00527.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2257.2003.00527.x</ArticleId><ArticleId IdType="pubmed">12890165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudolo G.B., Wang W., Barrientos J., Elrod R., Blodgett J. The Ingestion of Ginkgo Biloba Extract (EGb 761) Inhibits Arachidonic Acid-Mediated Platelet Aggregation and Thromboxane B2 Production in Healthy Volunteers. J. Herb. Pharmacother. 2004;4:13&#x2013;26. doi: 10.1080/J157v04n04_02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/J157v04n04_02</ArticleId><ArticleId IdType="pubmed">15927922</ArticleId></ArticleIdList></Reference><Reference><Citation>Snitz B.E. Ginkgo Biloba for Preventing Cognitive Decline in Older AdultsA Randomized Trial. JAMA. 2009;302:2663. doi: 10.1001/jama.2009.1913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1913</ArticleId><ArticleId IdType="pmc">PMC2832285</ArticleId><ArticleId IdType="pubmed">20040554</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon P.R., Adams F., Silver A., Zimmer J., DeVeaux R. Ginkgo for Memory Enhancement: A Randomized Controlled Trial. JAMA. 2002;288:835. doi: 10.1001/jama.288.7.835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.7.835</ArticleId><ArticleId IdType="pubmed">12186600</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge H.H., Zitzelberger T., Oken B.S., Howieson D., Kaye J. A Randomized Placebo-Controlled Trial of Ginkgo Biloba for the Prevention of Cognitive Decline. Neurology. 2008;70:1809&#x2013;1817. doi: 10.1212/01.wnl.0000303814.13509.db.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000303814.13509.db</ArticleId><ArticleId IdType="pmc">PMC2639649</ArticleId><ArticleId IdType="pubmed">18305231</ArticleId></ArticleIdList></Reference><Reference><Citation>Akanchise T., Angelova A. Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants. 2023;12:393. doi: 10.3390/antiox12020393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12020393</ArticleId><ArticleId IdType="pmc">PMC9952277</ArticleId><ArticleId IdType="pubmed">36829952</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Al-Jamal K.T., Kostarelos K., Reineke J. Physiologically Based Pharmacokinetic Modeling of Nanoparticles. ACS Nano. 2010;4:6303&#x2013;6317. doi: 10.1021/nn1018818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/nn1018818</ArticleId><ArticleId IdType="pubmed">20945925</ArticleId></ArticleIdList></Reference><Reference><Citation>De Matteis V., Rinaldi R. Toxicity Assessment in the Nanoparticle Era. In: Saquib Q., Faisal M., Al-Khedhairy A.A., Alatar A.A., editors. Cellular and Molecular Toxicology of Nanoparticles. Volume 1048. Springer International Publishing; Cham, Switzerland: 2018. pp. 1&#x2013;19. Advances in Experimental Medicine and Biology.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-72041-8_1</ArticleId><ArticleId IdType="pubmed">29453529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashok A., Andrabi S.S., Mansoor S., Kuang Y., Kwon B.K., Labhasetwar V. Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants. 2022;11:408. doi: 10.3390/antiox11020408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11020408</ArticleId><ArticleId IdType="pmc">PMC8869281</ArticleId><ArticleId IdType="pubmed">35204290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan S., Archunan G., Sivakumar M., Tamil Selvan S., Fred A.L., Kumar S., Guly&#xe1;s B., Padmanabhan P. Theranostic Applications of Nanoparticles in Neurodegenerative Disorders. IJN. 2018;13:5561&#x2013;5576. doi: 10.2147/IJN.S149022.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S149022</ArticleId><ArticleId IdType="pmc">PMC6154717</ArticleId><ArticleId IdType="pubmed">30271147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelperina S., Kisich K., Iseman M.D., Heifets L. The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis. Am. J. Respir. Crit. Care Med. 2005;172:1487&#x2013;1490. doi: 10.1164/rccm.200504-613PP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200504-613PP</ArticleId><ArticleId IdType="pmc">PMC2718451</ArticleId><ArticleId IdType="pubmed">16151040</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady R. A Novel Intranasal Breath-Powered Delivery System for Sumatriptan: A Review of Technology and Clinical Application of the Investigational Product AVP-825 in the Treatment of Migraine. Expert Opin. Drug Deliv. 2015;12:1565&#x2013;1577. doi: 10.1517/17425247.2015.1060959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425247.2015.1060959</ArticleId><ArticleId IdType="pubmed">26119828</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K., Hasegawa M., Kametani S., Ito S. Nose-to-Brain Delivery of TS-002, Prostaglandin D 2 Analogue. J. Drug Target. 2007;15:59&#x2013;66. doi: 10.1080/10611860601029496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10611860601029496</ArticleId><ArticleId IdType="pubmed">17365274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood S., Jain K., Gowthamarajan K. Intranasal Therapeutic Strategies for Management of Alzheimer&#x2019;s Disease. J. Drug Target. 2014;22:279&#x2013;294. doi: 10.3109/1061186X.2013.876644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1061186X.2013.876644</ArticleId><ArticleId IdType="pubmed">24404923</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonvico F., Clementino A., Buttini F., Colombo G., Pescina S., Stanis&#xe7;uaski Guterres S., Raffin Pohlmann A., Nicoli S. Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics. 2018;10:34. doi: 10.3390/pharmaceutics10010034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics10010034</ArticleId><ArticleId IdType="pmc">PMC5874847</ArticleId><ArticleId IdType="pubmed">29543755</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D., Minko T. Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics. 2021;13:2049. doi: 10.3390/pharmaceutics13122049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13122049</ArticleId><ArticleId IdType="pmc">PMC8704573</ArticleId><ArticleId IdType="pubmed">34959331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z., Yan Z., Hu K., Pang Z., Cheng X., Guo L., Zhang Q., Jiang X., Fang L., Lai R. Odorranalectin-Conjugated Nanoparticles: Preparation, Brain Delivery and Pharmacodynamic Study on Parkinson&#x2019;s Disease Following Intranasal Administration. J. Control. Release. 2011;151:131&#x2013;138. doi: 10.1016/j.jconrel.2011.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2011.02.022</ArticleId><ArticleId IdType="pubmed">21362449</ArticleId></ArticleIdList></Reference><Reference><Citation>Karavelioglu Z., Cakir-Koc R. Preparation of Chitosan Nanoparticles as Ginkgo Biloba Extract Carrier: In Vitro Neuroprotective Effect on Oxidative Stress-Induced Human Neuroblastoma Cells (SH-SY5Y) Int. J. Biol. Macromol. 2021;192:675&#x2013;683. doi: 10.1016/j.ijbiomac.2021.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.10.023</ArticleId><ArticleId IdType="pubmed">34655582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Zhao X., Yang F., Wu W., Liu Y., Wang L., Wang L., Wang Z. Enhanced Bioaccessibility in Vitro and Bioavailability of Ginkgo Biloba Extract Nanoparticles Prepared by Liquid Anti-solvent Precipitation. Int. J. Food Sci. Technol. 2019;54:2266&#x2013;2276. doi: 10.1111/ijfs.14141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijfs.14141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Xiong S., Liu P., Liu W., Wang Q., Liu Y., Tan H., Chen X., Shi X., Wang Q., et al. Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson&#x2019;s Disease. IJN. 2020;15:10453&#x2013;10467. doi: 10.2147/IJN.S272831.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S272831</ArticleId><ArticleId IdType="pmc">PMC7769078</ArticleId><ArticleId IdType="pubmed">33380795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan S., Kapil R., Singh B. Formulation Development and Systematic Optimization of Solid Lipid Nanoparticles of Quercetin for Improved Brain Delivery. J. Pharm. Pharmacol. 2011;63:342&#x2013;351. doi: 10.1111/j.2042-7158.2010.01225.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2042-7158.2010.01225.x</ArticleId><ArticleId IdType="pubmed">21749381</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi P., Ghaffari S., Arbabi Bidgoli S., Qomi M., Haghighat S. Preparation, Characterization and Evaluation of Ginkgo Biloba Solid Lipid Nanoparticles. Nanomed. Res. J. 2018;3:71&#x2013;78. doi: 10.22034/nmrj.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.22034/nmrj.2018.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Feng Q., Wang M., Zhao H., Lin Y., Zhou S. Green Biosynthesized Silver Nanoparticles With Aqueous Extracts of Ginkgo Biloba Induce Apoptosis via Mitochondrial Pathway in Cervical Cancer Cells. Front. Oncol. 2020;10:575415. doi: 10.3389/fonc.2020.575415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.575415</ArticleId><ArticleId IdType="pmc">PMC7606942</ArticleId><ArticleId IdType="pubmed">33194686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Ma R., Liu P., Cheng G., Yang Q., Chen X., Wu Z., Yuan D., Chen T. Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson&#x2019;s Disease. Pharmaceutics. 2022;14:1731. doi: 10.3390/pharmaceutics14081731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14081731</ArticleId><ArticleId IdType="pmc">PMC9415969</ArticleId><ArticleId IdType="pubmed">36015354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Huo Q., Quan Q., Yang X., Yu N., Wang Y. Optimizing the Formulation for Ginkgolide B Solid Dispersion. Open Life Sci. 2018;13:253&#x2013;262. doi: 10.1515/biol-2018-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/biol-2018-0031</ArticleId><ArticleId IdType="pmc">PMC7874724</ArticleId><ArticleId IdType="pubmed">33817091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Yang H., Wang T., Wang C. Green Synthesis and Antimicrobial Activity of Monodisperse Silver Nanoparticles Synthesized Using Ginkgo Biloba Leaf Extract. Phys. Lett. A. 2016;380:3773&#x2013;3777. doi: 10.1016/j.physleta.2016.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physleta.2016.09.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman A.S., Abu-Risha S.E., Bakr S.M., Altyar A.E., Fayad E., EL-Sawi M.R., EL-Kholy W.M. Comparative Study between Effects of Ginkgo Biloba Extract and Extract Loaded on Gold Nanoparticles on Hepatotoxicity Induced by Potassium Bromate. Environ. Sci. Pollut. Res. 2023;30:5027&#x2013;5036. doi: 10.1007/s11356-022-22324-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-22324-1</ArticleId><ArticleId IdType="pubmed">35978237</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazly E.H., Nasr A., Elnosary M.E., Gouda G.A., Mohamed H., Song Y. Identifying the Anti-MERS-CoV and Anti-HcoV-229E Potential Drugs from the Ginkgo Biloba Leaves Extract and Its Eco-Friendly Synthesis of Silver Nanoparticles. Molecules. 2023;28:1375. doi: 10.3390/molecules28031375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28031375</ArticleId><ArticleId IdType="pmc">PMC9919260</ArticleId><ArticleId IdType="pubmed">36771041</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifaai R.A., Mokhemer S.A., Saber E.A., El-Aleem S.A.A., El-Tahawy N.F.G. Neuroprotective Effect of Quercetin Nanoparticles: A Possible Prophylactic and Therapeutic Role in Alzheimer&#x2019;s Disease. J. Chem. Neuroanat. 2020;107:101795. doi: 10.1016/j.jchemneu.2020.101795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2020.101795</ArticleId><ArticleId IdType="pubmed">32464160</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanzadeh Jajin E., Esmaeili A., Rahgozar S., Noorbakhshnia M. Quercetin-Conjugated Superparamagnetic Iron Oxide Nanoparticles Protect AlCl3-Induced Neurotoxicity in a Rat Model of Alzheimer&#x2019;s Disease via Antioxidant Genes, APP Gene, and MiRNA-101. Front. Neurosci. 2021;14:598617. doi: 10.3389/fnins.2020.598617.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.598617</ArticleId><ArticleId IdType="pmc">PMC7947204</ArticleId><ArticleId IdType="pubmed">33716639</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Wen J., Garg S., Zhang W., Teng L.R., Liu D., Zhou Y. Development of a Novel Niosomal System for Oral Delivery of Ginkgo Biloba Extract. IJN. 2013;8:421&#x2013;430. doi: 10.2147/IJN.S37984.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S37984</ArticleId><ArticleId IdType="pmc">PMC3559077</ArticleId><ArticleId IdType="pubmed">23378764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmi I., Al-Abbasi F.A., Afzal M., Altayb H.N., Nadeem M.S., Gupta G. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics. 2021;13:2086. doi: 10.3390/pharmaceutics13122086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13122086</ArticleId><ArticleId IdType="pmc">PMC8707119</ArticleId><ArticleId IdType="pubmed">34959368</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas H., Sayed N.S.E., Youssef N.A.H.A., Gaafar P.M.E., Mousa M.R., Fayez A.M., Elsheikh M.A. Novel Luteolin-Loaded Chitosan Decorated Nanoparticles for Brain-Targeting Delivery in a Sporadic Alzheimer&#x2019;s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways. Pharmaceutics. 2022;14:1003. doi: 10.3390/pharmaceutics14051003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14051003</ArticleId><ArticleId IdType="pmc">PMC9148113</ArticleId><ArticleId IdType="pubmed">35631589</ArticleId></ArticleIdList></Reference><Reference><Citation>Settu K., Vaiyapuri M. FORMULATION AND EVALUATION OF ISORHAMNETIN LOADED POLY LACTIC-CO-GLYCOLIC ACID NANOPARTICLES. Asian J. Pharm. Clin. Res. 2017;10:177. doi: 10.22159/ajpcr.2017.v10i11.19918.</Citation><ArticleIdList><ArticleId IdType="doi">10.22159/ajpcr.2017.v10i11.19918</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Sun J., Cui F., Zhang T., Liu X., He Z. Self-Emulsifying Drug Delivery Systems for Improving Oral Absorption of Ginkgo Biloba Extracts. Drug Deliv. 2008;15:477&#x2013;484. doi: 10.1080/10717540802039089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10717540802039089</ArticleId><ArticleId IdType="pubmed">18720135</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Wu C., Fan G., Li T., Gong H., Cao F. Ginkgo Biloba Extracts-Loaded Starch Nano-Spheres: Preparation, Characterization, and in Vitro Release Kinetics. Int. J. Biol. Macromol. 2018;106:148&#x2013;157. doi: 10.1016/j.ijbiomac.2017.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2017.08.012</ArticleId><ArticleId IdType="pubmed">28780415</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremer-Hoffmann S., Halamoda-Kenzaoui B., Borgos S.E. Identification of Regulatory Needs for Nanomedicines: Regulatory Needs for Nanomedicines. J. Interdiscip. Nanomed. 2018;3:4&#x2013;15. doi: 10.1002/jin2.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jin2.34</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourdikoudis S., Pallares R.M., Thanh N.T.K. Characterization Techniques for Nanoparticles: Comparison and Complementarity upon Studying Nanoparticle Properties. Nanoscale. 2018;10:12871&#x2013;12934. doi: 10.1039/C8NR02278J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8NR02278J</ArticleId><ArticleId IdType="pubmed">29926865</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria M., Bj&#xf6;rnmalm M., Thurecht K.J., Kent S.J., Parton R.G., Kavallaris M., Johnston A.P.R., Gooding J.J., Corrie S.R., Boyd B.J., et al. Minimum Information Reporting in Bio&#x2013;Nano Experimental Literature. Nature Nanotech. 2018;13:777&#x2013;785. doi: 10.1038/s41565-018-0246-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-018-0246-4</ArticleId><ArticleId IdType="pmc">PMC6150419</ArticleId><ArticleId IdType="pubmed">30190620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>